ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial
Ann Surg Oncol. 2026 Jun;33(6):5026-5027.
doi: 10.1245/s10434-026-19430-6.
1 Peter MacCallum Cancer Centre, and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. eyal_more@hotmail.com.
2 Surgical Oncology Unit, Division of Surgery, Sheba Medical Center, affiliated with Tel Aviv University, Tel Aviv, Israel. eyal_more@hotmail.com.
3 Peter MacCallum Cancer Centre, and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
4 University of Ottawa, Ottawa, Canada.
5 University of Alabama at Birmingham, Birmingham, Alabama, USA.
6 Department of Surgery, Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA.
7 Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
8 Department of Surgery, Weill Cornell Medicine, New York, NY, USA.
9 Department of Surgery, NYU Langone Health, New York, NY, USA.
10 Division of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
11 Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.
12 Melanoma Institute Australia, Sydney, NSW, Australia.
13 Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
14 Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
15 Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
16 Department of Oncologic Sciences, University of South Florida, Morsani College of Medicine, Tampa, FL, USA.